BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Singh JA, Gaffo A. Gout epidemiology and comorbidities. Seminars in Arthritis and Rheumatism 2020;50:S11-6. [DOI: 10.1016/j.semarthrit.2020.04.008] [Cited by in Crossref: 20] [Cited by in F6Publishing: 11] [Article Influence: 10.0] [Reference Citation Analysis]
Number Citing Articles
1 Liu YR, Tantoh DM, Lin CC, Hsiao CH, Liaw YP. Risk of gout among Taiwanese adults with ALDH-2 rs671 polymorphism according to BMI and alcohol intake. Arthritis Res Ther 2021;23:115. [PMID: 33858492 DOI: 10.1186/s13075-021-02497-9] [Reference Citation Analysis]
2 Almeida C, Neves MC, Freire MG. Towards the Use of Adsorption Methods for the Removal of Purines from Beer. Molecules 2021;26:6460. [PMID: 34770869 DOI: 10.3390/molecules26216460] [Reference Citation Analysis]
3 Patel AV, Gaffo AL. Managing Gout in Women: Current Perspectives. JIR 2022;Volume 15:1591-8. [DOI: 10.2147/jir.s284759] [Reference Citation Analysis]
4 Daoussis D, Kordas P, Varelas G, Michalaki M, Onoufriou A, Mamali I, Iliopoulos G, Melissaropoulos K, Ntelis K, Velissaris D, Tzimas G, Georgiou P, Vamvakopoulou S, Paliogianni F, Andonopoulos AP, Georgopoulos N. ACTH vs steroids for the treatment of acute gout in hospitalized patients: a randomized, open label, comparative study. Rheumatol Int 2022. [PMID: 35445840 DOI: 10.1007/s00296-022-05128-x] [Reference Citation Analysis]
5 Lu Y, Fang L, Xu X, Wu Y, Li J. MicroRNA-142-3p facilitates inflammatory response by targeting ZEB2 and activating NF-κB signaling in gouty arthritis. Cell Cycle 2022;:1-15. [PMID: 35239453 DOI: 10.1080/15384101.2022.2031678] [Reference Citation Analysis]
6 Patil T, Soni A, Acharya S. A brief review on in vivo models for Gouty Arthritis. Metabol Open 2021;11:100100. [PMID: 34189452 DOI: 10.1016/j.metop.2021.100100] [Reference Citation Analysis]
7 Daoussis D, Bogdanos DP, Dimitroulas T, Sakkas L, Andonopoulos AP. Adrenocorticotropic hormone: an effective "natural" biologic therapy for acute gout? Rheumatol Int 2020;40:1941-7. [PMID: 32715340 DOI: 10.1007/s00296-020-04659-5] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
8 Yang Y, Cheng Y, Wang X, Upreti B, Cui R, Liu S, Shan B, Yu H, Luo C, Xu J. Gout Is Not Just Arthritis: Abnormal Cortical Thickness and Structural Covariance Networks in Gout. Front Neurol 2021;12:662497. [PMID: 34603178 DOI: 10.3389/fneur.2021.662497] [Reference Citation Analysis]
9 El Miedany Y, Gadallah NA, Mansour M, El Gaafary M, Mortada M, Eissa M, Hassan M, Hassan W, Tabra SA, Foad N, Ali R, Medhat B, Adel Y, Ghaleb R, Elkaraly N, Saber S, Galal S. Egyptian consensus on treat-to-target approach of gout: evidence-based clinical practice guidelines for the management of gout. Egypt Rheumatol Rehabil 2022;49. [DOI: 10.1186/s43166-022-00123-3] [Reference Citation Analysis]
10 Kim SY, Yoo DM, Kim JH, Kwon MJ, Kim J, Lee JW, Bang WJ, Choi HG. The Occurrence of Nephrolithiasis in Gout Patients: A Longitudinal Follow-Up Study Using a National Health Screening Cohort. Life 2022;12:653. [DOI: 10.3390/life12050653] [Reference Citation Analysis]
11 Chen G, Guo T, Yang L. Paeonol reduces IL-β production by inhibiting the activation of nucleotide oligomerization domain-like receptor protein-3 inflammasome and nuclear factor-κB in macrophages. Biochem Cell Biol 2021;:1-9. [PMID: 34784237 DOI: 10.1139/bcb-2021-0255] [Reference Citation Analysis]
12 Nutmakul T. A review on benefits of quercetin in hyperuricemia and gouty arthritis. Saudi Pharmaceutical Journal 2022. [DOI: 10.1016/j.jsps.2022.04.013] [Reference Citation Analysis]
13 Madrid-García A, León-Mateos L, Pato E, Jover JA, Fernández-Gutiérrez B, Abasolo L, Menasalvas E, Rodríguez-Rodríguez L. Predictors of health-related quality of life in musculoskeletal disease patients: a longitudinal analysis. Ther Adv Musculoskelet Dis 2021;13:1759720X211034063. [PMID: 34367344 DOI: 10.1177/1759720X211034063] [Reference Citation Analysis]
14 Abhishek A, Tata LJ, Mamas M, Avery AJ. Has the gout epidemic peaked in the UK? A nationwide cohort study using data from the Clinical Practice Research Datalink, from 1997 to across the COVID-19 pandemic in 2021. Ann Rheum Dis 2022:annrheumdis-2021-221989. [PMID: 35086817 DOI: 10.1136/annrheumdis-2021-221989] [Reference Citation Analysis]
15 He YS, Wang GH, Wu Q, Wu ZD, Chen Y, Tao JH, Fang XY, Xu Z, Pan HF. The Relationship Between Ambient Air Pollution and Hospitalizations for Gout in a Humid Subtropical Region of China. J Inflamm Res 2021;14:5827-35. [PMID: 34764674 DOI: 10.2147/JIR.S329706] [Reference Citation Analysis]
16 García-Maturano JS, Torres-Ordaz DE, Mosqueda-Gutiérrez M, Gómez-Ruiz C, Vázquez-Mellado A, Tafoya-Amado A, Peláez-Ballestas I, Burgos-Vargas R, Vázquez-Mellado J. Gout during the SARS-CoV-2 pandemic: increased flares, urate levels and functional improvement. Clin Rheumatol 2021. [PMID: 34822044 DOI: 10.1007/s10067-021-05994-z] [Reference Citation Analysis]
17 Sandoval-Plata G, Morgan K, Abhishek A. Are polymorphisms affecting serum urate, renal urate handling and alcohol intake associated with co-morbidities in gout cases? A case-control study using data from the UK Biobank. Rheumatol Int 2022. [PMID: 35633389 DOI: 10.1007/s00296-022-05148-7] [Reference Citation Analysis]
18 Wei JC, Chang Y, Wang Y, Yeh C. The Risk of Gout in Patients with Psoriasis: A Population-Based Cohort Study in Taiwan. CLEP 2022;Volume 14:265-73. [DOI: 10.2147/clep.s346128] [Reference Citation Analysis]
19 Lai SW, Hwang BF, Kuo YH, Liu CS, Liao KF. A meta-analysis of allopurinol therapy and the risk of prostate cancer. Medicine (Baltimore) 2022;101:e28998. [PMID: 35356907 DOI: 10.1097/MD.0000000000028998] [Reference Citation Analysis]
20 Weaver JS, Vina ER, Munk PL, Klauser AS, Elifritz JM, Taljanovic MS. Gouty Arthropathy: Review of Clinical Manifestations and Treatment, with Emphasis on Imaging. J Clin Med 2021;11:166. [PMID: 35011907 DOI: 10.3390/jcm11010166] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
21 Koo BS, Jeong H, Son C, Kim S, Kim G, Jun J. J-shaped Relationship Between Chronic Kidney Disease and Serum Uric Acid Levels: A Cross-sectional Study on the Korean Population. J Rheum Dis 2021;28:225-33. [DOI: 10.4078/jrd.2021.28.4.225] [Reference Citation Analysis]
22 Zhu M, Pan J, Hu X, Zhang G. Epicatechin Gallate as Xanthine Oxidase Inhibitor: Inhibitory Kinetics, Binding Characteristics, Synergistic Inhibition, and Action Mechanism. Foods 2021;10:2191. [PMID: 34574301 DOI: 10.3390/foods10092191] [Reference Citation Analysis]
23 Liu W, Song H, Man S, Li H, Gao S. Simple metabolic markers associated with tophaceous gout. Clin Rheumatol 2021. [PMID: 34264406 DOI: 10.1007/s10067-021-05861-x] [Reference Citation Analysis]
24 Xu X, Yi H, Wu J, Kuang T, Zhang J, Li Q, Du H, Xu T, Jiang G, Fan G. Therapeutic effect of berberine on metabolic diseases: Both pharmacological data and clinical evidence. Biomed Pharmacother 2021;133:110984. [PMID: 33186794 DOI: 10.1016/j.biopha.2020.110984] [Cited by in Crossref: 12] [Cited by in F6Publishing: 10] [Article Influence: 6.0] [Reference Citation Analysis]
25 Nawaz MZ, Ain Q, Zahid S, Zulfiqar T, Attique SA, Bilal M, Alghamdi HA, Yan W, Iqbal HMN. Physicochemical features and structural analysis of xanthine oxidase as a potential therapeutic target to prevent gout. Journal of Radiation Research and Applied Sciences 2020;13:616-28. [DOI: 10.1080/16878507.2020.1812807] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
26 Diaz-Torne C, Ortiz MA, Garcia-Guillen A, Jeria-Navarro S, Sainz L, Fernandez-Sanchez S, Corominas H, Vidal S. The inflammatory role of silent urate crystal deposition in intercritical gout. Rheumatology (Oxford) 2021:keab335. [PMID: 33839783 DOI: 10.1093/rheumatology/keab335] [Reference Citation Analysis]
27 Danve A, Sehra ST, Neogi T. Role of diet in hyperuricemia and gout. Best Pract Res Clin Rheumatol 2021;35:101723. [PMID: 34802900 DOI: 10.1016/j.berh.2021.101723] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
28 Benavent D, Peiteado D, Martinez-Huedo MÁ, Hernandez-Hurtado M, Balsa A, de Miguel E. Healthcare-related impact of gout in hospitalized patients in Spain. Sci Rep 2021;11:13287. [PMID: 34168227 DOI: 10.1038/s41598-021-92673-3] [Reference Citation Analysis]
29 Chen Y, Ma H, Du Y, Dong J, Jin C, Tan L, Wei R. Functions of 1,25-dihydroxy vitamin D3, vitamin D3 receptor and interleukin-22 involved in pathogenesis of gout arthritis through altering metabolic pattern and inflammatory responses. PeerJ 2021;9:e12585. [PMID: 34917427 DOI: 10.7717/peerj.12585] [Reference Citation Analysis]
30 Bao H, Qi Y, Wei B, Ma B, Wang Y, Xu Y. Severe erosive lesion of the glenoid in gouty shoulder arthritis: a case report and review of the literature. BMC Musculoskelet Disord 2021;22:343. [PMID: 33845812 DOI: 10.1186/s12891-021-04217-5] [Reference Citation Analysis]
31 Eun Y, Kim IY, Han K, Lee KN, Lee DY, Shin DW, Kang S, Lee S, Cha HS, Koh EM, Lee J, Kim H. Association between female reproductive factors and gout: a nationwide population-based cohort study of 1 million postmenopausal women. Arthritis Res Ther 2021;23:304. [PMID: 34915918 DOI: 10.1186/s13075-021-02701-w] [Reference Citation Analysis]
32 Lorenzo JPP, Sollano MHMZ, Salido EO, Li-Yu J, Tankeh-Torres SA, Wulansari Manuaba IAR, Rahman MM, Paul BJ, Mok MY, De Silva M, Padhan P, Lim AL, Marcial M, Vicera JJ, Haq SA, Salman S, Liyanage CK, Keen HI, Yew Kuang C, Wei JC, Hellmi RY, Chan CE Jr, Louthrenoo W. 2021 Asia-Pacific League of Associations for Rheumatology clinical practice guideline for treatment of gout. Int J Rheum Dis 2022;25:7-20. [PMID: 34931463 DOI: 10.1111/1756-185X.14266] [Reference Citation Analysis]
33 Shen L, Dong H, Guo Z, Zhai G, Zhang K. Identification of Abnormal Proteins in Plasma from Gout Patients by LC-MS/MS. Separations 2021;8:85. [DOI: 10.3390/separations8060085] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
34 Fogacci F, Borghi C, Di Micoli A, Degli Esposti D, Cicero AFG. Inequalities in enrollment of women and racial minorities in trials testing uric acid lowering drugs. Nutr Metab Cardiovasc Dis 2021;31:3305-13. [PMID: 34656384 DOI: 10.1016/j.numecd.2021.09.011] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
35 Jiang N, Xu C, Zhang L, Chen J. "Resurrected" human-source urate oxidase with high uricolytic activity and stability. Enzyme Microb Technol 2021;149:109852. [PMID: 34311889 DOI: 10.1016/j.enzmictec.2021.109852] [Reference Citation Analysis]
36 Salvatore T, Pafundi PC, Galiero R, Gjeloshi K, Masini F, Acierno C, Di Martino A, Albanese G, Alfano M, Rinaldi L, Sasso FC. Metformin: A Potential Therapeutic Tool for Rheumatologists. Pharmaceuticals (Basel) 2020;13:E234. [PMID: 32899806 DOI: 10.3390/ph13090234] [Cited by in Crossref: 8] [Cited by in F6Publishing: 8] [Article Influence: 4.0] [Reference Citation Analysis]
37 Banerjee M, Pal R, Mukhopadhyay S. Can SGLT2 inhibitors prevent incident gout? A systematic review and meta-analysis. Acta Diabetol 2022;59:783-91. [PMID: 35249140 DOI: 10.1007/s00592-022-01866-3] [Reference Citation Analysis]
38 Kiltz U, Buschhorn-milberger V, Vaupel K, Braun J. Gicht: aktuelle Epidemiologie, Komorbiditäten, Komplikationen und sozioökonomische Konsequenzen. Aktuelle Rheumatologie 2021;46:36-41. [DOI: 10.1055/a-1301-1793] [Reference Citation Analysis]